Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maintenance immunosuppression.

S K Takemoto

    Clinical Transplants
    |September 6, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Immunosuppressive drug trends in kidney transplants show Tacrolimus and MMF becoming dominant, leading to decreased rejection rates. HLA matching also improved outcomes across various immunosuppression strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
    Same author

    Outcomes of simultaneous heart-kidney transplant in the US: a retrospective analysis using OPTN/UNOS data.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
    Same author

    A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
    Same author

    Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
    Same author

    Lack of interventional studies in renal transplant candidates with elevated cardiovascular risk.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
    Same author

    Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.

    Transplantation proceedings·2005
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Transplantation Medicine

    Background:

    • Immunosuppressive therapy is crucial for preventing kidney transplant rejection.
    • Understanding trends in immunosuppressive agent use and their impact on outcomes is vital for optimizing patient care.

    Purpose of the Study:

    • To analyze the administration trends of primary and adjunctive immunosuppressive agents in kidney transplantation.
    • To evaluate the impact of these trends on rejection rates and graft outcomes across different recipient types and HLA matching statuses.

    Main Methods:

    • An intent-to-treat analysis of data from the UNOS Registry of Renal Transplant Recipients.
    • Examination of immunosuppressive agent administration by year of transplant for various recipient categories (unsensitized, sensitized, multi-organ, living donor).

    Related Experiment Videos

  • Assessment of rejection rates and graft outcomes in relation to specific immunosuppression combinations and HLA matching.

    • Main Results:

    • Tacrolimus emerged as the dominant primary agent, and Mycophenolate Mofetil (MMF) as the dominant adjunctive agent across transplant types by the early 2000s.
    • Rejection rates significantly decreased from 60% in 1996 to 20% in 2001, with the Tacrolimus-MMF combination showing the lowest rates.
    • HLA matching was associated with reduced rejection and improved graft outcomes, though the most potent immunosuppression (Tacrolimus-MMF) did not always yield the best graft outcome in HLA-matched living donor transplants.

    Conclusions:

    • Shifting immunosuppressive strategies towards Tacrolimus and MMF have coincided with a substantial reduction in kidney transplant rejection.
    • HLA matching remains a critical factor in improving both rejection rates and long-term graft survival.
    • The interplay between immunosuppression potency, HLA matching, and graft outcome warrants further investigation, particularly in specific transplant scenarios like HLA-matched living donor transplants.